Adjuvant chemotherapy for non-small cell lung cancer.

Journal Article (Journal Article;Review)

The survival after complete resection for non-small cell lung cancer (NSCLC) is unsatisfactory. Until recently, the use of adjuvant therapy after resection for early stage disease has not been proven to improve survival. However, the efficacy of adjuvant therapy has been demonstrated in phase III prospective randomized trials. The appropriate use of adjuvant therapy, including biologic therapy, is currently under investigation.

Full Text

Duke Authors

Cited Authors

  • D'Amico, TA

Published Date

  • 2005

Published In

Volume / Issue

  • 17 / 3

Start / End Page

  • 195 - 198

PubMed ID

  • 16253822

International Standard Serial Number (ISSN)

  • 1043-0679

Digital Object Identifier (DOI)

  • 10.1053/j.semtcvs.2005.06.010


  • eng

Conference Location

  • United States